Additional points to consider before incorporating the Food and Drug Administration-approved therapies for systemic sclerosis-associated interstitial lung disease: comment on the article by Khanna et al.
Arthritis Rheumatol
; 74(4): 733-734, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1772650
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Lung Diseases, Interstitial
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Arthritis Rheumatol
Year:
2022
Document Type:
Article
Affiliation country:
Art.41993
Similar
MEDLINE
...
LILACS
LIS